Australia markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,304.65+0.40 (+0.03%)
At close: 03:43PM IST
Full screen
Previous close1,304.25
Open1,302.05
Bid1,303.00 x 0
Ask1,304.90 x 0
Day's range1,286.25 - 1,327.00
52-week range723.40 - 1,327.00
Volume33,497
Avg. volume50,917
Market cap763.442B
Beta (5Y monthly)0.55
PE ratio (TTM)24.10
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield4.50 (0.35%)
Ex-dividend date20 Feb 2024
1y target estN/A
  • Investing.com

    Aurobindo Pharma Outperforms Expectations with Strong Q4, Eyes Robust Growth Ahead

    Aurobindo Pharma (NS:ARBN) has outperformed expectations in the fourth quarter of FY24, with both sales and EBITDA showing significant year-over-year growth. Sales increased by 17%, while EBITDA surged by an impressive 68%, surpassing both Goldman Sachs (NYSE:GS)' projections and those of the broader market. The EBITDA margin also exceeded forecasts, reaching 22.3%, which is 101 basis points higher than Goldman Sachs' estimate.